Shares of Prosus (OTCMKTS:PROSY – Get Rating) have earned a consensus recommendation of “Buy” from the seven analysts that are presently covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $89.85.
PROSY has been the subject of a number of analyst reports. JPMorgan Chase & Co. decreased their price objective on shares of Prosus from €47.00 ($51.09) to €45.40 ($49.35) and set a “neutral” rating for the company in a report on Friday, March 25th. Barclays decreased their price objective on shares of Prosus from €115.90 ($125.98) to €76.00 ($82.61) and set an “overweight” rating for the company in a report on Monday, March 28th. The Goldman Sachs Group initiated coverage on shares of Prosus in a report on Thursday, January 20th. They set a “buy” rating for the company. Morgan Stanley decreased their price objective on shares of Prosus from €122.00 ($132.61) to €110.00 ($119.57) in a report on Thursday, March 24th. Finally, Investec cut shares of Prosus from a “buy” rating to a “hold” rating in a report on Friday, February 11th.
Shares of OTCMKTS PROSY opened at $10.22 on Monday. The firm has a 50 day moving average price of $12.13 and a 200 day moving average price of $15.10. Prosus has a 52-week low of $9.06 and a 52-week high of $23.17.
Prosus N.V. engages in the e-commerce and internet businesses. It operates internet platforms, such as classifieds, payments and fintech, food delivery, travel, education, etail, health, social, and other internet platforms. It has operations in the Americas, the Middle East, Africa, Central and Eastern Europe, and Asia.
- Get a free copy of the StockNews.com research report on Prosus (PROSY)
- Levi Straus Stock Ready to Buy the Dip
- Bed Bath & Beyond Stock Ready to Scale Into
- Institutions And Analysts Drive UnitedHealth Group Higher
- MarketBeat: Week in Review 4/11 – 4/15
- Three Beaten Down Mega Caps The Analysts Are Upgrading
Receive News & Ratings for Prosus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prosus and related companies with MarketBeat.com's FREE daily email newsletter.